Brandt L J, Spinnell M K
Division of Gastroenterology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York 10467, USA.
Gastrointest Endosc. 1999 Jan;49(1):79-83. doi: 10.1016/s0016-5107(99)70449-9.
Colon vascular ectasias are a common cause of lower intestinal bleeding among the elderly. The lesions may be difficult to diagnose at colonoscopy because they are small and their appearance may be influenced by the patient's blood pressure, blood volume, and narcotic sedation during the procedure. The purpose of this study was to determine whether naloxone influenced the appearance of colon vascular ectasias at colonoscopy.
One hundred forty-four patients older than 60 years undergoing complete colonoscopy participated in the study. Medications were given in the usual doses. After a 2-minute inspection of the cecum and ascending colon, naloxone was given, followed by another 2-minute observation period. Photographic documentation of areas of interest was obtained before and after administration of naloxone.
One hundred fourteen patients (79%) had no ectasias before or after administration of naloxone. Fourteen (9.7%) initially had normal vessels, and the vessels became more prominent; 4 (2.7%) initially had no ectasias, but ectasias later developed. Four patients (2.7%) had ectasias before administration of naloxone that did not change; 8 (5.4%) had ectasias before administration of naloxone that increased in size (3 patients), number (7 patients), or both (2 patients).
Naloxone can enhance the appearance of normal colonic vasculature and ectasias. Naloxone is an important adjunctive medication for patients undergoing examinations for lower intestinal bleeding.
结肠血管扩张是老年人下消化道出血的常见原因。这些病变在结肠镜检查时可能难以诊断,因为它们很小,并且其外观可能受到患者血压、血容量以及检查过程中麻醉镇静的影响。本研究的目的是确定纳洛酮是否会影响结肠镜检查时结肠血管扩张的外观。
144名年龄超过60岁且正在接受全结肠镜检查的患者参与了该研究。药物以常规剂量给予。在对盲肠和升结肠进行2分钟检查后,给予纳洛酮,随后再进行2分钟观察期。在给予纳洛酮前后获取感兴趣区域的摄影记录。
114名患者(79%)在给予纳洛酮前后均无扩张。14名患者(9.7%)最初血管正常,之后血管变得更加明显;4名患者(2.7%)最初无扩张,但后来出现了扩张。4名患者(2.7%)在给予纳洛酮前有扩张,且未发生变化;8名患者(5.4%)在给予纳洛酮前有扩张,其大小(3名患者)、数量(7名患者)或两者(2名患者)有所增加。
纳洛酮可增强正常结肠血管系统和扩张的外观。纳洛酮是接受下消化道出血检查患者的重要辅助药物。